Connect with us
European Gaming Congress 2024

Artificial Intelligence

Thyroid Cancer Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Novartis, AffyImmune Therapeutics, Eli Lilly, Loxo Oncology, Bristol-Myers Squibb, and Others Expected to Propel Market

Published

on

<!– Name:DistributionId Value:8806314 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1204938 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:0e87f1b9-569f-4201-99d9-32c16850c80d –>

New York, USA, April 12, 2023 (GLOBE NEWSWIRE) — Thyroid Cancer Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Novartis, AffyImmune Therapeutics, Eli Lilly, Loxo Oncology, Bristol-Myers Squibb, and Others Expected to Propel Market

The thyroid cancer market is anticipated to show positive growth in the coming years owing to the extensive research and development activities of pharmaceutical companies and the expected launch of approved therapies in the seven major markets.

DelveInsight’s Thyroid Cancer Market Insights report includes a comprehensive understanding of current treatment practices, thyroid cancer emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].

Key Takeaways from the Thyroid Cancer Market Report

Advertisement
Stake.com
  • As per DelveInsight analysis, the thyroid cancer market is expected to grow positively owing to several underline factors during the study period (2019–2032).
  • As per a study by the American Cancer Society (2022), the most recent estimates for thyroid cancer in the United States are about 43,800 new cases of thyroid cancer, accounting for 11,860 cases in men and 31,940 cases in women.
  • Leading thyroid cancer companies such as Novartis, AffyImmune Therapeutics, Eli Lilly, Loxo Oncology, Bristol-Myers Squibb, Merck Sharp & Dohme LLC, Genentech, Inc., Bayer, Eisai Inc., AffyImmune Therapeutics, Inc., Millennium Pharmaceuticals, Inc., Exelixis, Sanofi, Hoffmann-La Roche, DualityBio Inc., Turning Point Therapeutics, Inc., Boston Pharmaceuticals, TransThera Sciences, Theratechnologies, ABM Therapeutics Corporation, and others are developing novel thyroid cancer drugs that can be available in the thyroid cancer market in the coming years.
  • Some of the key therapies for thyroid cancer treatment include Dabrafenib +Trametinib, AIC100, LOXO-260, Nivolumab + Ipilimumab, Pembrolizumab, Vemurafenib, Regorafenib, LENVATINIB, AIC100 CAR T Cells, MLN0128, Cabozantinib, Vandetanib, BLU-667, DB-1202, LOXO-292, TPX-0046, BOS172738, TT-00420, TH1902, BAY2757556, ABM-1310, and others.
  • Several thyroid cancer therapies are awaiting approval, while some therapies are in the advanced stages of development. 

Discover which therapies are expected to grab the major thyroid cancer market share @ Thyroid Cancer Market Report

Thyroid Cancer Overview

Thyroid cancer is a type of cancer that begins in the thyroid gland’s tissues. Thyroid cancer is classified into three types: papillary (including Hürthle’s papillary, follicular, and papillary), medullary, and anaplastic (aggressive form). Most thyroid cancers are differentiated, and when examined in the lab, the cells in these cancers resemble normal thyroid tissue. Thyroid cancer can cause any of the following signs or symptoms: a lump in the neck, which can grow quickly, pain in the front of the neck, difficulty swallowing, and so on. The thyroid cancer diagnosis procedure includes reviewing the medical history and performing a physical exam that may include imaging tests, biopsy, blood tests, and a vocal cord exam, also known as laryngoscopy.

Tiny thyroid cancers exist undetected in up to one-third of all adults’ glands, and the vast majority of these are never detected or cause any clinical problems. As tiny nodules are difficult to biopsy accurately, any nodule smaller than 1 centimeter in size may not require further evaluation.

Thyroid Cancer Epidemiology Segmentation

As per Surveillance, Epidemiology, and End Results (SEER), thyroid cancer accounts for 43,800 new cases in the US in 2022.

Advertisement
Stake.com

The thyroid cancer market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Incident Cases of Thyroid Cancer
  • Age-specific Cases of Thyroid Cancer
  • Gender-specific Incident Cases of Thyroid Cancer
  • Stage-specific Incident Cases of Thyroid Cancer 
  • Type-specific Incident Cases of Thyroid Cancer
  • Total Treated Cases of Thyroid Cancer

Download the report to understand which factors are driving thyroid cancer epidemiology trends @ Thyroid Cancer Epidemiological Insights

Thyroid Cancer Treatment Market 

Radiation therapy, hormonal therapy, chemotherapy, targeted drug therapy, and surgery are all part of the thyroid cancer treatment regimen. The stage of cancer determines thyroid cancer treatment following surgery. Radioactive iodine (RAI) therapy is sometimes used after thyroidectomy for early-stage cancers (T1 or T2), but RAI therapy is more commonly used for more advanced cancers such as T3 or T4 tumors or cancers that have spread to lymph nodes or distant areas. The goal is to destroy any remaining thyroid tissue while also attempting to treat any cancer that may still be present in the body.

Moreover, the US FDA approved Cabometyx (Cabozantinib) in September 2021 for the treatment of patients with locally advanced or metastatic DTC who had progressed after prior VEGFR-targeted therapy and were ineligible or refractory to radioactive iodine. In addition, Ipsen announced in May 2022 that the European Commission (EC) had approved Cabometyx as a monotherapy for the treatment of adult patients with locally advanced or metastatic differentiated thyroid carcinoma (DTC), refractory or ineligible to radioactive iodine who progressed during or after prior systemic therapy. Exelixisha retains US rights, while its partner Ipsen retains rights for indications outside of the US and Japan, and Takeda retains Japanese rights.

To know more about thyroid cancer treatment, visit @ Thyroid Cancer Treatment Drugs 

Advertisement
Stake.com

Key Thyroid Cancer Therapies and Companies

  • Dabrafenib +Trametinib: Novartis
  • AIC100: AffyImmune Therapeutics
  • LOXO-260:Eli Lilly/Loxo Oncology
  • Nivolumab + Ipilimumab: Bristol-Myers Squibb
  • Pembrolizumab: Merck Sharp & Dohme LLC
  • Vemurafenib: Genentech, Inc.
  • Regorafenib: Bayer
  • LENVATINIB: Eisai Inc.
  • AIC100 CAR T Cells: AffyImmune Therapeutics, Inc.
  • MLN0128: Millennium Pharmaceuticals, Inc.
  • Cabozantinib: Exelixis
  • Vandetanib: Sanofi 
  • BLU-667: Hoffmann-La Roche
  • DB-1202: DualityBio Inc.
  • LOXO-292: Loxo Oncology, Inc./Eli Lilly and Company
  • TPX-0046: Turning Point Therapeutics, Inc.
  • BOS172738: Boston Pharmaceuticals
  • TT-00420: TransThera Sciences
  • TH1902: Theratechnologies
  • BAY2757556: Bayer
  • ABM-1310: ABM Therapeutics Corporation

Learn more about the FDA-approved drugs for thyroid cancer @ Drugs for Thyroid Cancer Treatment 

Thyroid Cancer Market Dynamics

The dynamics of the thyroid cancer market are anticipated to change in the coming years owing to the improvement in the rise in the number of healthcare spending across the world. In addition, the rising awareness of the disease is also propelling the growth of the thyroid cancer market. Moreover, numerous approved thyroid cancer therapies exist, which is a significant market mover. Thyroid cancer incidence has increased in the past, resulting in a larger patient pool, thus propelling the thyroid cancer market growth. Thyroid cancer is becoming more common as the world’s population grows, creating more opportunities for research and development in the thyroid cancer market.

Moreover, the thyroid cancer pipeline is very robust; many potential therapies are being investigated to treat thyroid cancer, and it is safe to predict that the treatment space will significantly impact the thyroid cancer market during the forecast period. The expected introduction of emerging therapies with improved efficacy and a further improvement in the diagnosis rate are expected to drive the growth of the thyroid cancer market in the 7MM.

However, the thyroid cancer market growth may be hampered by failures and discontinuation of emerging therapies, unaffordable pricing, market access and reimbursement issues, and a shortage of healthcare specialists.  In addition, the undiagnosed, unreported cases and the unawareness about the disease may also impact the thyroid cancer market growth. Moreover, thyroid cancer is difficult to diagnose in the early stages because it is mostly asymptomatic, making diagnosis and treatment difficult. Furthermore, there is fierce competition among marketed drugs. The scarcity of effective emerging therapies in the late stages of development will cause a dip in the growth of the thyroid cancer market. 

Advertisement
Stake.com
Report Metrics Details
Study Period 2019–2032
Coverage 7MM [The United States, the EU-4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan]
Base Year 2019
Key Thyroid Cancer Companies Novartis, AffyImmune Therapeutics, Eli Lilly, Loxo Oncology, Bristol-Myers Squibb, Merck Sharp & Dohme LLC, Genentech, Inc., Bayer, Eisai Inc., AffyImmune Therapeutics, Inc., Millennium Pharmaceuticals, Inc., Exelixis, Sanofi, Hoffmann-La Roche, DualityBio Inc., Turning Point Therapeutics, Inc., Boston Pharmaceuticals, TransThera Sciences, Theratechnologies, ABM Therapeutics Corporation, and others
Key Thyroid Cancer Therapies Dabrafenib +Trametinib, AIC100, LOXO-260, Nivolumab + Ipilimumab, Pembrolizumab, Vemurafenib, Regorafenib, LENVATINIB, AIC100 CAR T Cells, MLN0128, Cabozantinib, Vandetanib, BLU-667, DB-1202, LOXO-292, TPX-0046, BOS172738, TT-00420, TH1902, BAY2757556, ABM-1310, and others

Scope of the Thyroid Cancer Market Report

  • Therapeutic Assessment: Thyroid Cancer current marketed and emerging therapies
  • Thyroid Cancer Market Dynamics: Attribute Analysis of Emerging Thyroid Cancer drugs
  • Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
  • Unmet Needs, KOL’s views, Analyst’s views, Thyroid Cancer Market Access and Reimbursement

Discover more about thyroid cancer drugs in development @ Thyroid Cancer Clinical Trials

Table of Contents

1. Thyroid Cancer Market Key Insights
2. Thyroid Cancer Market Report Introduction
3. Thyroid Cancer Market Overview at a Glance
4. Thyroid Cancer Market Executive Summary
5. Disease Background and Overview
6. Thyroid Cancer Treatment and Management
7. Thyroid Cancer Epidemiology and Patient Population
8. Patient Journey
9. Thyroid Cancer Marketed Drugs
10. Thyroid Cancer Emerging Drugs
11. Seven Major Thyroid Cancer Market Analysis
12. Thyroid Cancer Market Outlook
13. Potential of Current and Emerging Therapies
14. KOL Views
15. Thyroid Cancer Market Drivers
16. Thyroid Cancer Market Barriers
17. Unmet Needs
18. SWOT Analysis
19. Appendix
20. DelveInsight Capabilities
21. Disclaimer
22. About DelveInsight

Related Reports

Thyroid Cancer Pipeline

Thyroid Cancer Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key thyroid cancer companies, including Bristol-Myers Squibb, Genentech, AffyImmune Therapeutics, Inc., Taizhou Hanzhong biomedical co. LTD, among others.

Advertisement
Stake.com

Thyroid Cancer Epidemiology Forecast

Thyroid Cancer Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical, and forecasted thyroid cancer epidemiology in the 7MM.

Thyroid Hormone Receptor Agonists Pipeline

Thyroid Hormone Receptor Agonists Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key thyroid hormone receptor agonists companies such as Terns Pharmaceuticals, Ascletis, Autobahn Therapeutics, among others.

Papillary Thyroid Cancer Pipeline

Advertisement
Stake.com

Papillary Thyroid Cancer Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key papillary thyroid cancer companies such as the University of Colorado, Assiut University, University Health Network, among others.

Medullary Thyroid Cancer Pipeline

Medullary Thyroid Cancer Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key medullary thyroid cancer companies such as Eli Lilly, Exelixis, Columbia University, among others.

Anaplastic Thyroid Cancer Pipeline

Anaplastic Thyroid Cancer Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key anaplastic thyroid cancer companies such as Novartis, AstraZeneca, Fujian Medical University, among others.

Advertisement
Stake.com

Other Trending Reports

Treatment Resistant Depression Market | Advanced Renal Cell Carcinoma Market | Thyroid Cancer Market | Centronuclear Myopathy Market | Head And Neck Squamous Cell Carcinoma Market | Acquired Immunodeficiency Syndrome Market | Acute Intermittent Porphyria Market | Neurovascular Devices Market | Defibrillators Market | Ventricular Hypertrophy Market | Urolithiasis Market | Alopecia Areata Market | Autonomic Dysfunction Market | Acute Ischemic Stroke Ais Market | Adenoid Cystic Carcinoma Market | Aspergillosis Market | Biliary Atresia Market | Biliary Tumor Market | Chronic Inducible Urticaria Market | Chronic Insomnia Market | Critical Limb Ischemia Market | Endometriosis Pain Market | Generalized Anxiety Disorder Gad Market | Hallux Valgus Market | Hemophilia B Market | Immunologic Deficiency Syndrome Market | Thyroid Cancer Market | Neuromodulation Devices Market | Neurovascular Thrombectomy Devices Market | Osteosarcoma Market | Pemphigus Vulgaris Market | Progressive Familial Intrahepatic Cholestasis Market | Pruritus Market | Radiation Toxicity Market | Pulmonary Hypertension Associated With Interstitial Lung Disease Market | Cluster Headaches Market | Foot And Ankle Devices Market | Intravenous Immunoglobulin Market | Bile Duct Neoplasm Market | Blood Glucose Monitoring Systems Market | Rett Syndrome Market | Tissue Heart Valves Market | Cardiac Biomarkers Testing Devices Market | Subscription Healthcare | Hepatorenal Syndrome Market | Central Venous Catheters Market | Continuous Renal Replacement Therapy Machines Market | Nonalcoholic Steatohepatitis Market | Necrotizing Enterocolitis Market | Cardiac Amyloidosis Market | Artificial Iris Market | Aortic Aneurysm Stent Grafts Market | Polypoidal Choroidal Vasculopathy Market | Adrenal Crisis Market | Hearing Implants Market | Image Guided Surgery Devices Market | Angioedema Market | Bladder Cancer Market

Related Healthcare Services

Healthcare Consulting

Healthcare Competitive Intelligence Services

Advertisement
Stake.com

Healthcare Asset Prioritization Services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect with us on LinkedIn|Facebook|Twitter


Advertisement
Stake.com

Artificial Intelligence

Securden Recognized as a Market Leader in GigaOm Radar Report for Enterprise Password Management

Published

on

securden-recognized-as-a-market-leader-in-gigaom-radar-report-for-enterprise-password-management

Securden has become a leader and an outperformer with cutting-edge features, rapid market advancements, and consistent customer value.
WILMINGTON, Del., July 4, 2024 /PRNewswire/ — Securden, Inc., a leading provider of privileged access and identity security solutions, today announced that it has been recognized as a leader and outperformer in GigaOm Radar Report for Enterprise Password Management.

GigaOm rigorously evaluates vendors in various solution segments and produces Radar reports with valuable insights to assist enterprise decision-makers in evaluating and investing in solutions.
The GigaOm Radar 2024 on Enterprise Password Management examined 13 enterprise password management solutions. “Securden is positioned in the innovation quadrant. It offers a strong solution, and its approach is to take its customers on a journey to broader PAM, with password management simply one focus area. It scored well across all of the decision criteria we evaluated, placing it as a leader, and its execution of the emerging features and rate of progress in the market classify it as an Outperformer,” states the report.
Securden has earned top ratings in key evaluation criteria, including platform security, security auditing, PAM capabilities, ease of management, ease of use, and scalability.
“We are proud to be recognized as a market leader in Enterprise Password Management by GigaOm Radar,” said Bala Venkatramani, CEO of Securden, Inc. “Protecting various identities used by humans and machines is a top priority for IT teams. Our platform offers a comprehensive privileged identity security solution, witnessing rapid adoption by SMBs and Enterprises globally. With innovation at the core, we are committed to offering simplicity and affordability in cybersecurity. This recognition affirms our strong market presence and our focus on providing powerful capabilities to strengthen our customers’ security posture.”
Securden offers robust protection for the vault with controls like access hardening, resilient deployment, and strong data protection approaches. It offers insights into password usage, identifies poor practices, flags failure to follow password standards, issues breach warnings identifying compromised passwords, and more. These measures significantly help reduce password-related risks.
Streak of Recognition
EMA Research, a top industry analyst firm, recently published an impact brief recognizing the Securden Unified PAM MSP platform as a groundbreaking development in privileged access management for MSPs. “By eliminating the need for disparate PAM solutions and providing comprehensive functionality within a single package, Securden empowers MSPs to deliver robust, scalable, and secure PAM services to their clients with unparalleled efficiency and confidence,” states the impact brief.
About Securden
Securden provides leading privileged access governance and identity security solutions that uniquely combine critical security principles to prevent cyberattacks, malware propagation and insider exploitation. With products designed for security and scalability (Password Vault for Enterprises, Unified PAM, Endpoint Privilege Manager, and Unified PAM MSP), Securden is trusted by organizations worldwide, including large financial institutions, government agencies, healthcare organizations, educational institutions, IT service providers, MSPs, and manufacturing companies. For more information, visit https://www.securden.com.
Media ContactJames [email protected]
Logo – https://mma.prnewswire.com/media/2362812/securden_logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/securden-recognized-as-a-market-leader-in-gigaom-radar-report-for-enterprise-password-management-302189680.html

Continue Reading

Artificial Intelligence

Managed Security Services Market Forecast to Exceed USD 101.86 Billion by 2031 Due to Escalating Security Concerns | SkyQuest Technology

Published

on

managed-security-services-market-forecast-to-exceed-usd-101.86-billion-by-2031-due-to-escalating-security-concerns-|-skyquest-technology

WESTFORD, Mass., July 4, 2024 /PRNewswire/ — According to SkyQuest, the global Managed Security Services Market size was valued at USD 26.89 billion in 2022 and is poised to grow from USD 31.18 billion in 2023 to USD 101.86 billion by 2031, growing at a CAGR of 15.95% during the forecast period (2024-2031).

The global managed security services market has been growing rapidly, over the last couple of years, due to the increasing security threats or risks and increasing challenges in managing security over IT networks. It’s impossible to ignore the fact that small businesses face relentless cyberattacks, including malware, ransomware, advanced threats, advanced persistent threats, and data breaches, leading to remote and hybrid operations systems.
Download a detailed overview:
https://www.skyquestt.com/sample-request/managed-security-services-market
Managed Security Services Market Overview:
Report Coverage
Details
Market Revenue in 2023
USD 31.18 billion
Estimated Value by 2031
USD 101.86 billion
Growth Rate
Poised to grow at a CAGR of 15.95%
Forecast Period
2024–2031
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Service Type, Type, Organization Size, Security, Type and Industry Vertical
Geographies Covered
North America, Europe, Asia Pacific, and the Rest of the world
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Surge in Demand for Managed Detection and Response (MDR) Service
Key Market Drivers
Cyber Threats are Growing Complex 
Segments covered in Managed Security Services Market are as follows:
Service TypeManaged IAM, managed vulnerability management, managed risk and compliance, managed detection and response, managed firewall, and managed SIEM and log management, othersTypeFully managed, co-managedOrganization SizeSmall and medium-sized enterprises, Large enterprisesSecurity TypeNetwork security, cloud security, endpoint security, application security, othersIndustry VerticalBFSI, government, healthcare & life sciences, telecommunications, IT and ITeS, Retail and eCommerce, energy and utilities, manufacturing, and other verticalsRequest Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/managed-security-services-market
Rapid Responders: Incident Response Services
Managed detection and response are the large segment in the managed security services market. Managed detection-response services provide continuous improvement, threat detection, and response capabilities critical to today’s enterprises facing sophisticated cyber threats. This segment is characterized by the increasing prevalence and importance of cyberattacks advanced threat detection and response strategies beyond traditional security measures. The ability of the MDR service to provide comprehensive analysis of security incidents and take corrective action quickly is essential to minimize potential damage and ensure business continuity.
Managed identity and access management is the fastest growing segment in the market. The rising growth in this sector is driven by the need for robust stakeholder solutions in an era of digital transformation and remote collaboration. The rise of cyber threats and increasing regulatory requirements for data security and privacy and the main drivers of this segment.
Data Guardians: Data Protection Services
The global market recognizes the dominant position of the entire service management segment. This dominance is largely due to the scope of this role, in which companies assume full responsibility for an organization’s security programs from security providers, especially those without in-house security expertise or resources. These roles cover a wide range of security measures, including threat identification, incident response, compliance management and continuous monitoring. Adoption rates are also driven by the increasing complexity of cyber threats, which require a strong, 24/7 monitored security measure that only specialized providers can provide further strengthening its position as the largest market share.
In addition to the dominance of fully managed services, the advanced management segment is growing the fastest in the global market. This increase is driven by hybrid security models that offer a collaborative approach between internal IT teams and external security providers.
View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/managed-security-services-market
Safeguarding Tomorrow’s Digital Frontiers
As businesses and organizations take on the cyber panorama in terms of severe, MSS vendors remain vigilant guards, the use of advanced era and professional insights. Managed Security Services (MSS) have emerged as the cornerstone of present-day cybersecurity strategies, presenting strong protection in opposition to threats in a more and more digital international.
Related Report:
Cyber Security Market
Network Security Market
Endpoint Security Market
Cloud Security Market
Application Security Market
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization has expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact:Mr. Jagraj SinghSkyquest Technology1 Apache Way,Westford,Massachusetts 01886USA (+1) 351-333-4748Email: [email protected] Our Website: https://www.skyquestt.com/
Logo: https://mma.prnewswire.com/media/2446095/SkyQuest_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/managed-security-services-market-forecast-to-exceed-usd-101-86-billion-by-2031-due-to-escalating-security-concerns–skyquest-technology-302189493.html

Continue Reading

Artificial Intelligence

Industrial Internet of Things (IIoT) Market is Expected to Surpass USD 191.6 Billion Valuation by 2031, Rise of Automation in Manufacturing to Boost Expansion| SkyQuest Technology

Published

on

industrial-internet-of-things-(iiot)-market-is-expected-to-surpass-usd-191.6-billion-valuation-by-2031,-rise-of-automation-in-manufacturing-to-boost-expansion|-skyquest-technology

WESTFORD, Mass., July 4, 2024 /PRNewswire/ — According to SkyQuest, the global Industrial Internet of Things (IIoT) Market was valued at USD 102.48 Billion in 2022 and is expected to rise from USD 109.86 Billion in 2023 to reach a value of USD 191.6 Billion by 2031, at a CAGR of 7.2% during the forecast period (2024-2031).

The rapid adoption of smart manufacturing practices in multiple industries and growing demand for automation have set the tone for industrial internet of things (IIoT) market growth. IIoT devices and solutions are specifically designed to enhance industrial operations and promote operational efficiency and productivity as well. Advancements in IoT and IoT connectivity technologies are also slated to create new business scope for industrial internet of things (IIoT) companies in the future.  The global industrial internet of things (IIoT) market is segmented into component, technology, connectivity technology, software, vertical, and region.
Download a detailed overview:
https://www.skyquestt.com/sample-request/industrial-internet-of-things-iiot-market
Industrial Internet of Things (IIoT) Market Overview: 
Report Coverage
Details
Market Revenue in 2023
$ 109.86 billion
Estimated Value by 2031
$ 191.6 billion
Growth Rate
Poised to grow at a CAGR of 7.2%
Forecast Period
2024–2031
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Component, Technology, Connectivity Technology, Software and Vertical
Geographies Covered
North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Report Highlights
Development of novel blockchain AI solutions that give benefits of both technologies involved
Key Market Opportunities
Adoption of Smart Initiatives
Key Market Drivers
Implementation of IPV6
Segments covered in Industrial Internet of Things (IIoT) Market are as follows:
ComponentHardware, Platform, Solution, and ServicesTechnologySensor, Radio Frequency Identification (RFID), Industrial Robotics, Distributed Control System and OtherConnectivity TechnologyWired Technology and Wireless TechnologySoftwareVisualization Software, SCADA, Distribution Management System, Farm Management Systems and OtherVerticalManufacturing, Energy, Oil & Gas, HealthCare, Retail, Transportation, Metal & Mining, AgricultureRequest Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/industrial-internet-of-things-iiot-market
Hardware Components Slated to Bring in Most Revenue Owing to Development of IIoT Infrastructure
Industrial internet of things (IIoT) requires specialized connected devices made from dedicated sensors and controllers. Growing investments in the development of new IIoT infrastructure are projected to bolster the demand for hardware components and allow this segment to lead the market in terms of revenue generation. Advancements in connectivity technologies are also predicted to bolster the demand for novel IIoT hardware components across the forecast period and beyond.
Meanwhile, industrial internet of things (IIoT) companies can also invest in the development of novel platforms and services to strengthen their business potential. The need for IIoT platforms and services will only get stronger by the day as the adoption of IoT technology in industrial settings increases.
Manufacturing to Take the Crown for Industrial Internet of Things (IIoT) Sales Owing to the Rise of Smart Factories
The manufacturing industry vertical is estimated to take center stage when it comes to industrial internet of things (IIoT) adoption. High demand for better productivity and operational efficiency in manufacturing facilities is estimated to make this segment a highly lucrative one. From remote monitoring to predictive maintenance, all of these features can only be added to a manufacturing facility through the use of industrial internet of things (IIoT). Energy and oil & gas industry verticals are also forecasted to provide moneymaking opportunities for industrial internet of things (IIoT) companies in the future as digitization increases in them. Apart from these industry verticals, industrial internet of things (IIoT) providers can also explore retail, healthcare, agriculture, and transportation industry verticals to maximize their business scope and boost revenue generation going forward.
View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/industrial-internet-of-things-iiot-market
Wireless Connectivity to Gain Prominence with the Advent of 5G Technology
Advancements in technology have created novel wireless technologies used for connected devices. The need for the elimination of wires is projected to drive the demand for wireless connectivity in industrial internet of things (IIoT) devices. 5G is the key wireless connectivity technology that is projected to help the wireless segment become the most rewarding for market players over the coming years.
Industrial internet of things providers will need to choose their strategies carefully if they want to succeed in this business. Industrial internet of things (IIoT) companies can get good returns on their investments if they target the manufacturing industry as the trend of automation catches up. Developing new IIoT hardware devices and components will also help industrial internet of things (IIoT) companies expand their business potential on a global level. 
Related Reports:
Internet Of Things (IoT) Market
IoT Security Market 
Narrowband-IoT (NB-IoT) Market
Consumer IoT Market
Internet of Things (IoT) in Smart Cities Market 
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization has expanded our reach across North America, Europe, ASEAN and Asia Pacific. 
Contact:Mr. Jagraj SinghSkyQuest Technology1 Apache Way,Westford,Massachusetts 01886USA (+1) 351-333-4748Email: [email protected] Our Website: https://www.skyquestt.com/
Logo: https://mma.prnewswire.com/media/2446095/SkyQuest_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/industrial-internet-of-things-iiot-market-is-expected-to-surpass-usd-191-6-billion-valuation-by-2031–rise-of-automation-in-manufacturing-to-boost-expansion-skyquest-technology-302189485.html

Continue Reading

Trending